by Ariana | Jul 30, 2025 | Article
Dr. Mohamed Osman to Investigate the Biological Causes of Fatigue in Lupus Lupus Canada and the Lupus Foundation of America are proud to announce Dr. Mohamed Osman, MD, PhD, of the University of Alberta as the recipient of the 2025 Lupus Canada Catalyst Award. His...
by Ariana | Apr 15, 2025 | Article
Understanding Lupus Care & Access Across Provinces in Canada Take the Survey Participate in Our National Lupus Treatment Access Survey Join us in our mission to improve access to lupus treatment across Canada. This national survey aims to understand the challenges...
by Ariana | Mar 31, 2025 | Article
Click Here to Participate Lupus Research Study: Pain Mapping & Psychosocial Predictors of Depressive Symptoms in Individuals with Lupus Lupus (Systemic Lupus Erythematosus) is an autoimmune disease frequently associated with chronic pain and depression. This lupus...
by Ariana | Mar 27, 2025 | Article
How Anifrolumab Helps Reduce Organ Damage in Lupus Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can cause widespread inflammation and irreversible organ damage. Managing SLE effectively requires controlling disease activity, preventing...
by Ariana | Mar 27, 2025 | Article
Learn how the TULIP trials demonstrated that anifrolumab significantly improves rates of lupus low disease activity state (LLDAS) and remission in SLE patients. Anifrolumab is one of the only two biologic treatments approved for patients with moderate to severe SLE....